Drugs / BCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07551544 Comparator | May 2026 → May 2032 | non-invasive bladder urothelial carcinoma | ImmunityBio, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07551544 ↗ |
| Route | Other | “50 mg BCG intravesically, weekly for 6 consecutive weeks” NCT07551544 ↗ |